You are here

  • Home
  • Archive
  • Volume 59, Issue 7
  • Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis

Article info

Article menu
Download PDFPDF
Inflammatory bowel disease
Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis

Authors

  1. Correspondence to Ulrich Steinhoff, Max-Planck Institute for Infection Biology, Charitéplatz 1, D-10117 Berlin, Germany; steinhoff{at}mpiib-berlin.mpg.de
View Full Text

Citation

Schmidt N, Gonzalez E, Visekruna A, et al
Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis
Gut 2010;59:896-906.

Publication history

  • Revised February 3, 2010
  • Accepted February 10, 2010
  • First published June 25, 2010.
Online issue publication 
April 18, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.